Evaluation of Neuromuscular ElectroStimulation in Addition to a Physical Activity Program
Key facts
- Who runs it
- GCS Ramsay Santé pour l'Enseignement et la Recherche
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Terminated
- People taking part
- 28 people enrolled
- Started
- 20 Dec 2023
- Ended
- 4 Aug 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- activity sessions
- Record updated
- 2 October 2026
- Why it stopped
- Recruitment has slowed considerably in recent months, making it particularly difficult to enroll new participants. This slowdown is partly due to recent changes in the management of prostate cancer.
Who can take part
- Age
- 18 years to 90 years
- Sex
- Men only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 18 criteriaShow less
Who can take part
- Patient treated with pharmacological androgen deprivation therapy for prostate cancer for more than 26 weeks
- Performance index (WHO): 0 or 1
- Patient able to understand the information related to the study, to read the information leaflet and having consented to participate in the study
- Patient benefiting from a social security scheme
Who cannot take part
- Absolute contraindication to physical training (e.g. musculoskeletal, cardiovascular or neurological disorders), according to the doctor specializing in the associated medical condition
- Contraindication to the use of the neuromuscular electrostimulation device or the impedance meter, in particular infectious disease in the acute phase, fungal infection, dermatitis, unbalanced arrhythmia, epilepsy, wearing an active implantable device (pacemaker, heart artificial, prosthesis incorporating an electromagnetic system), open wound
- Anemia (hemoglobin < 10 g/dL)
- Thrombocytopenia (platelets < 50 G/L)
- Renal impairment (creatinine clearance < 60 mL/min, or albuminuria > 30)
- Weight ≥ 130 kg
- Vegetarian food
- Other associated neoplasia
- Patient having undergone a bilateral orchiectomy
- Painful bone metastases, or at risk of fracture
- Patient planning to travel more than 4 weeks continuously in the next 52 weeks
- Sports activity already supervised by a third party or at an equal or higher level than the bodybuilding/muscle strengthening work recommended in the study
- Protected adult patient (under guardianship or curatorship, or under a regime of deprivation of liberty)
- Patient participating in another research, or in a period of exclusion from another research
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The purpose of the study is to measure the muscle strength of the quadriceps 6 months from the start of the intervention, either the maximum load resistance that can be lifted in a single repetition under standardized conditions with the thigh press.
The 2 groups in the trial
- NeuroMuscular Electro Stimulation groupTreatment being tested
Patients in the NeuroMuscular Electro Stimulation group will also have neurostimulation sessions using a CE marked medical device, in its destination, according to its instructions for use, therefore without expected clinical risk
Treatment: activity sessions
- Control GroupExisting treatment, for comparison
The control group (without NeuroMuscular Electro Stimulation) corresponds to the standard care routinely offered to patients in the investigating centre.
Treatment: activity sessions
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Management of Patients Under Anti-HORMonal Treatment for Prostate Cancer : Evaluation of Neuromuscular ElectroStimulation in Addition to a Physical Activity Program
- Record updated
- 2 October 2026